ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MANNING HANLINE MD

Internal Medicine

22,496

$985K

628
475 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

MICHAEL FORSTHOEFEL M.D.

Internal Medicine

22,489

$1.47M

764
696 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

HAMIDREZA MOGHADDAM M.D.

Internal Medicine

22,420

$1.59M

724
484 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $56

JOSEPH SPERDUTO M.D.

Internal Medicine

22,357

$856K

1284
1213 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $56

VENKATESWARA NANDAM M.D.

Internal Medicine

22,322

$893K

803
573 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

SONALI KUMAR MD

Internal Medicine

22,255

$756K

767
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

MICHAEL STROBBE D.O.

Internal Medicine

22,229

$1.24M

1275
773 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

SARAH RODRIGUEZ M.D.

Internal Medicine

22,009

$798K

974
718 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

PARMINDER DHALIWAL MD

Internal Medicine

21,904

$636K

994
891 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $56

ERIC RANON MD

Internal Medicine

21,902

$955K

1014
491 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

VU TRAN MD

Internal Medicine

21,879

$752K

983
917 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

JOLLY JOSE MD

Internal Medicine

21,807

$424K

744
615 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $56

ROBERTO LLANTADA MD

Internal Medicine

21,786

$1.24M

751
664 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

REGINA PORTNOVA M.D.

Internal Medicine

21,755

$1.03M

543
499 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $56

ANTONIO MENDEZ MD

Internal Medicine

21,742

$785K

578
517 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

AURELIO TORRES CONSUEGRA MD

Internal Medicine

21,675

$1.94M

640
539 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $56

GEORGE SABATES M.D.

Internal Medicine

21,672

$673K

871
828 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

ANAIS CORTES MD

Internal Medicine

21,606

$1.79M

1207
1038 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $56

IAN BOYKIN MD

Internal Medicine

21,576

$1.42M

1240
1064 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

SYED SAFDAR M.D.

Internal Medicine

21,528

$829K

1182
937 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

ANTONIO BLANCO MD

Internal Medicine

21,443

$1.19M

1037
877 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

JOSEPH LEMAIRE MD

Internal Medicine

21,283

$1.03M

870
783 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

THOMAS LAMPONE M.D.

Internal Medicine

21,166

$1.21M

430
384 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

REGINA ASIHENE M.D.

Internal Medicine

21,113

$621K

801
691 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $56

ROBERTO FERNANDEZ BLAY MD

Internal Medicine

21,054

$675K

1398
1163 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank